Literature DB >> 11186308

Thirty-six views of T-cell recognition.

M Krummel1, C Wülfing, C Sumen, M M Davis.   

Abstract

While much is known about the signalling pathways within lymphocytes that are triggered during activation, much less is known about how the various cell surface molecules on T cells initiate these events. To address this, we have focused on the primary interaction that drives T-cell activation, namely the binding of a particular T-cell receptor (TCR) to peptide-MHC ligands, and find a close correlation between biological activity and off-rate; that is, the most stimulatory TCR ligands have the slowest dissociation rates. In general, TCRs from multiple histocompatibility complex (MHC) class-II-restricted T cells have half-lives of 1-11s at 25 degrees C, a much narrower range than found with antibodies and suggesting a strong selection for an optimum dissociation rate. TCR ligands with even faster dissociation rates tend to be antagonists. To observe the effects of these different ligands in their physiological setting, we made gene fusions of various molecules with green fluorescent protein (GFP), transfected them into the relevant lymphocytes, and observed their movements during T-cell recognition using multicolour video microscopy. We find that clustering of CD3zeta-GFP and CD4-GFP on the Tcell occurs concomitantly or slightly before the first rise in calcium by the T cell, and that various GFP-labelled molecules on the B-cell side cluster shortly thereafter (ICAM-1, class II MHC, CD48), apparently driven byT-cell molecules. Most of this movement towards the interface is mediated by signals through the co-stimulatory receptors, CD28 and LFA-1, and involves myosin motors and the cortical actin cytoskeleton. Thus, we have proposed that the principal mechanism by which co-stimulation enhances T-cell responsiveness is by increasing the local density of T-cell activation molecules, their ligands and their attendant signalling apparatus. In collaboration with Michael Dustin and colleagues, we have also found that the formation and stability of the TCR-peptide-MHC cluster at the centre of the interaction cap between T and B cells is highly dependent on the dissociation rate of the TCR and its ligand. Thus, we are able to link this kinetic parameter to the formation of a cell surface structure that is linked to and probably causal with respect to T-cell activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11186308      PMCID: PMC1692810          DOI: 10.1098/rstb.2000.0644

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  22 in total

1.  Immunological function of the thymus.

Authors:  J F MILLER
Journal:  Lancet       Date:  1961-09-30       Impact factor: 79.321

2.  Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection.

Authors:  R J Cornall; J G Cyster; M L Hibbs; A R Dunn; K L Otipoby; E A Clark; C C Goodnow
Journal:  Immunity       Date:  1998-04       Impact factor: 31.745

Review 3.  Ligand recognition by alpha beta T cell receptors.

Authors:  M M Davis; J J Boniface; Z Reich; D Lyons; J Hampl; B Arden; Y Chien
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

4.  Ligand-specific oligomerization of T-cell receptor molecules.

Authors:  Z Reich; J J Boniface; D S Lyons; N Borochov; E J Wachtel; M M Davis
Journal:  Nature       Date:  1997-06-05       Impact factor: 49.962

5.  CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics.

Authors:  P A van der Merwe; D L Bodian; S Daenke; P Linsley; S J Davis
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

6.  The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways.

Authors:  B A Irving; A Weiss
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

7.  Affinity and kinetic analysis of L-selectin (CD62L) binding to glycosylation-dependent cell-adhesion molecule-1.

Authors:  M W Nicholson; A N Barclay; M S Singer; S D Rosen; P A van der Merwe
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

8.  CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes.

Authors:  K C Garcia; C A Scott; A Brunmark; F R Carbone; P A Peterson; I A Wilson; L Teyton
Journal:  Nature       Date:  1996-12-12       Impact factor: 49.962

9.  Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59.

Authors:  P A van der Merwe; A N Barclay; D W Mason; E A Davies; B P Morgan; M Tone; A K Krishnam; C Ianelli; S J Davis
Journal:  Biochemistry       Date:  1994-08-23       Impact factor: 3.162

10.  Affinity and kinetic analysis of the interaction of the cell adhesion molecules rat CD2 and CD48.

Authors:  P A van der Merwe; M H Brown; S J Davis; A N Barclay
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

View more
  8 in total

1.  Wide-scale quantitative phosphoproteomic analysis reveals that cold treatment of T cells closely mimics soluble antibody stimulation.

Authors:  Qinqin Ji; Arthur R Salomon
Journal:  J Proteome Res       Date:  2015-04-03       Impact factor: 4.466

Review 2.  An extended vision for dynamic high-resolution intravital immune imaging.

Authors:  Ronald N Germain; Flora Castellino; Marcello Chieppa; Jackson G Egen; Alex Y C Huang; Lily Y Koo; Hai Qi
Journal:  Semin Immunol       Date:  2005-10-10       Impact factor: 11.130

3.  Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II.

Authors:  Dirk Homann; Hanna Lewicki; David Brooks; Jens Eberlein; Valerie Mallet-Designé; Luc Teyton; Michael B A Oldstone
Journal:  Virology       Date:  2007-02-21       Impact factor: 3.616

Review 4.  Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeutics.

Authors:  Chuda Chittasupho; Teruna J Siahaan; Charlotte M Vines; Cory Berkland
Journal:  Ther Deliv       Date:  2011-07

5.  Visualizing lipid raft dynamics and early signaling events during antigen receptor-mediated B-lymphocyte activation.

Authors:  Neetu Gupta; Anthony L DeFranco
Journal:  Mol Biol Cell       Date:  2003-02       Impact factor: 4.138

6.  Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency.

Authors:  Aleksandar K Stanic; A Dharshan De Silva; Jang-June Park; Venkataraman Sriram; Shinichi Ichikawa; Yoshio Hirabyashi; Kyoko Hayakawa; Luc Van Kaer; Randy R Brutkiewicz; Sebastian Joyce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

7.  IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17.

Authors:  Curtis J Henry; David A Ornelles; Latoya M Mitchell; Kristina L Brzoza-Lewis; Elizabeth M Hiltbold
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 8.  Organizing MHC Class II Presentation.

Authors:  David R Fooksman
Journal:  Front Immunol       Date:  2014-04-10       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.